Stockscreener 앱 받기
1.56
13.33%
-0.24
Proqr Therapeutics N V 주식(PRQR)의 최신 뉴스
1,181,413 Shares in ProQR Therapeutics (NASDAQ:PRQR) Acquired by ArrowMark Colorado Holdings LLC - MarketBeat
Invesco Ltd. Purchases Shares of 11,887 ProQR Therapeutics (NASDAQ:PRQR) - Defense World
ProQR Therapeutics (PRQR) Projected to Post Quarterly Earnings on Thursday - MarketBeat
ProQR Therapeutics (NASDAQ:PRQR) Shares Acquired by Boothbay Fund Management LLC - MarketBeat
ProQR Therapeutics N.V (NASDAQ: PRQR) Posted 2.58% Gain This Year: What’s Next? - Stocksregister
JPMorgan Chase & Co. Has $142,000 Holdings in ProQR Therapeutics (NASDAQ:PRQR) - Defense World
Equities Analysts Set Expectations for PRQR FY2025 Earnings - MarketBeat
Evercore ISI Initiates Coverage on ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat
ProQR Therapeutics (NASDAQ:PRQR) Now Covered by Analysts at Cantor Fitzgerald - MarketBeat
ProQR Therapeutics NV expected to post a loss of 9 cents a shareEarnings Preview - TradingView
ProQR Announces Webcast of Presentation at the 2025 Citizens Lif - GuruFocus
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference | PRQR Stock News - GuruFocus
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference - GlobeNewswire
RNA Editing Pioneer ProQR to Showcase Breakthrough Axiomer Platform at Major Healthcare Conference - Stock Titan
ProQR Therapeutics (NASDAQ:PRQR) Earns Outperform Rating from Analysts at Evercore ISI - Defense World
ProQR Therapeutics (NASDAQ:PRQR) Research Coverage Started at Cantor Fitzgerald - Defense World
Adage Capital Partners GP L.L.C. Purchases 5,976,813 Shares of ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat
ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 - GlobeNewswire
ProQR Therapeutics N.V [PRQR] Investment Appeal on the Rise - knoxdaily.com
RNA Editing Market Deep Research 2025-2032 | QIAGEN N.V., ProQR - openPR.com
Evercore ISI Group Initiates Coverage of ProQR Therapeutics N.V. (PRQR) with Outperform Recommendation - Nasdaq
ProQR Therapeutics assumed with an Overweight at Cantor Fitzgerald - Yahoo Finance
ProQR Therapeutics initiated with an Outperform at Evercore ISI - Yahoo Finance
XTX Topco Ltd Takes $163,000 Position in ProQR Therapeutics (NASDAQ:PRQR) - The AM Reporter
Riding the Waves: A Guide to Investing in PRQR Stock - investchronicle.com
ProQR Therapeutics (PRQR) Receives Overweight Rating and $8 Pric - GuruFocus
Cantor Fitzgerald sets $8 price target on ProQR shares with Overweight rating - Investing.com
ProQR Therapeutics (PRQR) Gains Outperform Rating from Evercore ISI | PRQR Stock News - GuruFocus
Evercore ISI sets ProQR stock Outperform with $5 target By Investing.com - Investing.com UK
Evercore ISI sets ProQR stock Outperform with $5 target - Investing.com
ProQR Therapeutics (NASDAQ:PRQR) Short Interest Update - MarketBeat
Walleye Capital LLC Buys New Position in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat
ProQR Therapeutics N.V (PRQR)’s Market Momentum: Closing Strong at 1.54, Up 6.21 - DWinneX
A new trading data show ProQR Therapeutics N.V (PRQR) is showing positive returns. - Sete News
Altium Capital Management LLC Takes $1.52 Million Position in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat
Citizens JMP reiterates ProQR stock with $8 target By Investing.com - Investing.com Nigeria
Can you now get a good deal on ProQR Therapeutics N.V’s shares? - uspostnews.com
Citizens JMP reiterates ProQR stock with $8 target - Investing.com
ProQR Therapeutics N.V (PRQR) Stock: A Year of Highs and Lows in the Market - investchronicle.com
ProQR Therapeutics (NASDAQ:PRQR) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Affinity Asset Advisors LLC Makes New Investment in ProQR Therapeutics (NASDAQ:PRQR) - MarketBeat
5.24%
자본화:
|
볼륨(24시간):